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Thrombospondin (Thbs) proteins are induced in sites
of tissue damage or active remodeling. The endo-
plasmic reticulum (ER) stress response is also prom-
inently induced with disease where it regulates
protein production and resolution of misfolded
proteins. Here we describe a function for Thbs as
ER-resident effectors of an adaptive ER stress
response. Thbs4 cardiac-specific transgenic mice
were protected from myocardial injury, whereas
Thbs4/ mice were sensitized to cardiac maladap-
tation. Thbs induction produced a unique profile of
adaptive ER stress response factors and expansion
of the ER and downstream vesicles. Thbs bind the
ER lumenal domain of activating transcription factor
6a (Atf6a) to promote its nuclear shuttling. Thbs4/
mice showed blunted activation of Atf6a and other
ER stress-response factors with injury, and Thbs4-
mediated protection was lost upon Atf6a deletion.
Hence, Thbs can function inside the cell during
disease remodeling to augment ER function and
protect through a mechanism involving regulation
of Atf6a.
INTRODUCTION
The endoplasmic reticulum (ER) stress response/unfolded
protein response (UPR) has been studied for nearly two
decades, and a role in many forms of human disease has been
uncovered (Glembotski, 2007; Zhang and Kaufman, 2008).
Engagement of the ER stress response acutely reduces protein
synthesis in the ER, enhances protein degradation of damaged
or misfolded proteins, and selectively induces expression of
protective proteins (Glembotski, 2007; Zhang and Kaufman,
2008). Although acute activation of the ER stress response is
protective, prolongation of the response typically leads to celldeath in the heart and other tissues (Zhang and Kaufman,
2008; Hamada et al., 2004; Cook et al., 2009; Xu et al., 2009).
The ER stress response is initiated within the ER lumen and
membrane through the chaperone protein BiP (Grp78) that
directly binds Ca2+ and senses unfolded or damaged proteins.
BiP then aids activation of three primary pathways: PKR-like
ER kinase (PERK), inositol-requiring enzyme 1a (IRE1a), and
activating transcription factor 6 (Atf6). PERK activation at the
ER membrane results in phosphorylation and inactivation of eu-
karyotic translation initiation factor 2a (eIF2a) to reduce protein
synthesis but also to selectively induce expression of the tran-
scription factor Atf4. The second branch involves IRE1a, which
is a kinase and RNAase that mediates selective splicing of the
message encoding the transcription factor XBP1. Finally, the
third branch involves Atf6, an ERmembrane-bound transcription
factor that shuttles with ER stress stimulation to the Golgi, where
it is cleaved into an active form that translocates to the nucleus.
Five thrombospondin (Thbs) genes are present in mammals
and encode secreted matricellular Ca2+-binding glycoproteins
involved in diverse biologic processes, given their ability to
bind numerous proteins and serve as interaction platforms in
the extracellular matrix (ECM) (Stenina et al., 2007; Kazerounian
et al., 2008). Thbs1 and 2 comprise a subfamily that forms homo-
and heterotrimers. They contain a procollagen-binding domain,
a type 1 repeat domain that binds transforming growth factor
b (TGF-b), and domains that bind b1 integrins, calreticulin, and
the CD36 and CD47 receptors (Kazerounian et al., 2008). In
contrast, Thbs3/4/5 constitute a different structural subfamily
that forms homo- and heteropentamers. This subfamily lacks
the procollagen domain and type 1 repeats, and family members
are less than 50% homologous to Thbs1 and 2 with presumably
divergent functions (Stenina et al., 2007; Kazerounian et al.,
2008). All five Thbs gene family members appear capable of
low-level ubiquitous expression in diverse tissues, although
each is dramatically induced by injury, stress, or acute remodel-
ing events (Kazerounian et al., 2008). For example, Thbs1,
Thbs2, Thbs3, and Thbs4 are each induced in the heart in
response to hypertrophy or infarction injury (Schroen et al.,
2004; Stenina et al., 2007), and loss of Thbs1 or Thbs2 inCell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc. 1257
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Figure 1. Thbs4 Expression Is Upregulated in Diseased Hearts and Is Protective
(A) Western blots for Thbs4 protein expression in different mouse models exhibiting cardiac disease.
(B) Schematic diagram representing the binary transgenic system regulated by doxycycline to inducibly overexpress Thbs4 in the heart.
(C) Representative western blot showing Thbs4 protein expression level in heart extracts from 4-month-old DTG mice versus WT and tTA-only transgenic
controls.
(D) Immunohistochemistry for Thbs4 (green) in 4-month-old mouse hearts. Red staining shows membranes, and blue shows nuclei (scale bars = 10 mm).
(E) Hemodynamic assessment of cardiac performance as maximal dP/dt in anesthetized, closed-chested mice in response to increasing doses of the
b-adrenergic agonist dobutamine (measured in mmHg/s; ± SD).
(F) Survival plot for tTA and DTG mice following MI injury (n = 10 male mice per group).
(G) Cardiac ventricular fractional shortening (FS%) determined by echocardiography. At least 6 mice were analyzed in each group at 2 and 4 weeks after MI injury
in the tTA control and DTG groups (#p < 0.05 versus tTA before MI).
(H) Survival plot in Thbs4/ and WT mice after pressure overload by TAC (n = 10 male mice per group).
Also see Figures S1 and S2.gene-targeted mice promoted greater cardiac disease with
aging or stress stimulation (Swinnen et al., 2009; Schroen
et al., 2004; Frangogiannis et al., 2005). Thbs1 and Thbs4 reside
within the ER, either indefinitely or for a period of time before
being secreted outside the cell, depending on Ca2+ levels or
the cell type that was examined (Veliceasa et al., 2007).
RESULTS
Thbs4 Is an Inducible ER/Vesicular Protein in the Heart
and Is Protective
Thbs4 was identified as a cardiac-induced gene in transgenic
mousemodels of heart disease, consistent with previous reports
in the literature (Gabrielsen et al., 2007; Mustonen et al., 2008).
Western blotting confirmed induction of Thbs4 protein in
the hearts of transgenic mice expressing activated calcineurin
(hypertrophic model) or myocyte enhancer factor 2A (Mef2A,
dilated cardiomyopathy), in Csrp3/ mice (muscle LIM protein
gene, dilated cardiomyopathy), and in mice with 2 weeks of
cardiac pressure overload stimulation by transverse aortic
constriction (TAC, Figure 1A). To model this induction of1258 Cell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc.Thbs4 and examine its functional effect, we generated two
lines of Thbs4-overexpressing transgenic mice using a
cardiac-specific binary tetracycline/doxycycline (Dox) regulated
system in which double-transgenic mice (DTG) express Thbs4
when Dox is removed from the diet (Sanbe et al., 2003) (Fig-
ure 1B). DTGmice (line 17.3) were removed fromDox at weaning
to several weeks later produce in young adult hearts moderate
expression of Thbs4 protein that approximated the level of
endogenous Thbs4 induced in hearts of our disease models
(Figure 1C).
Immunohistochemical analysis of endogenous or overex-
pressed Thbs4 from cardiac histological sections showed prom-
inent localization within intracellular vesicles and the ER/SR (SR,
sarcoplasmic reticulum) compartment of cardiac myocytes, with
some secretion into the extracellular space (Figure 1D and
Figures S1A and S1B available online). Importantly, Thbs4 was
evenly distributed within the ER/SR compartment, and aggrega-
tion was not apparent by microscopy (Figures S1A and S1B).
Induction of endogenous Thbs4 in the hearts of pressure-over-
loaded wild-type (WT) mice also showed intracellular localization
with minor accumulation in the extracellular space (Figure S1C).
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Figure 2. Unique ERStress-Induction Profile Asso-
ciated with Thbs4 Expression
(A) Western blots for expression of ER stress-response
proteins from the hearts of two lines of Thbs4 DTG mice
versus tTA control hearts.
(B) Immunohistochemistry for Atf6a and BiP (green) in
heart sections from tTA controls or Thbs4 DTG mice.
Membranes of the cardiomyocytes are shown in red (scale
bars = 10 mm).
(C) Increasing RT-PCR cycles for Atf6amRNA in hearts of
tTA control or Thbs4 DTG mice. Gapdh mRNA was used
as a loading/normalization control. The asterisk shows
increased Atf6amRNA in the DTG hearts at the most linear
cycle number in the RT-PCR reaction.
(D) Transmission EMof heart sections from tTA control and
Thbs4 DTG mice shows ER/SR and vesicles (arrowheads)
in control and Thbs4 DTG hearts.
(E) Luciferase activity in the media of NIH 3T3 cells trans-
fected with a plasmid encoding a secreted version of
luciferase that was cotransfected with Thbs4, Atf6a-D
(constitutively nuclear), or Atf4 (all internally normalized to
cotransfected b-gal plasmid). *p < 0.05 versus the lucif-
erase plasmid only. Error bars represent SD.
(F) Western blotting for the ER processed and secreted
proteins Armet and ANF from concentrated media of
neonatal rat cardiomyocytes previously infected with
adenoviruses encoding b-galactosidase (control), Thbs4,
or Thbs1.
Also see Figures S3 and S4.We also generated heart-specific Thbs1-overexpressing trans-
genic mice, which similarly showed intracellular ER localization
of Thbs1 protein, without significant ECM association (Fig-
ure S1D). Overexpression of Thbs1 and 4 in skeletal muscle by
transgenesis also showed primarily intracellular localization
consistent with the ER/SR compartment (data not shown).
Adult Thbs4 DTGmice showed no cardiac functional or struc-
tural abnormalities associated with persistent overexpression
during aging, or even with 12 weeks of pressure overload stimu-
lation by TAC (Figures S2A–S2C). Assessment of cardiac
ventricular performance by invasive hemodynamics also
showednormal cardiac function and responsiveness to a b-adre-
nergic receptor agonist in Thbs4 DTGmice comparedwith single
transgenic controls expressing the tetracycline transactivator
protein (tTA, Figure 1E). Moreover, Thbs4 DTG mice were pro-
tected from lethality and maintained better cardiac function
following myocardial infarction (MI) injury compared with tTA
controls (Figures 1F and 1G), and Thbs4 DTG mice showed no
detriment after 12 weeks of TAC stimulation (Figure S2C). ThisCell 149, 1effect was specific to the heart because Thbs4
skeletal muscle-specific overexpressing trans-
genic mice were not protected from MI injury
(data not shown). Antithetically, Thbs4/ mice
were more susceptible to lethality and decom-
pensation following TAC stimulation over
4 weeks (Figure 1H), as well as following MI
injury (Figures S2D and S2E), further suggesting
that Thbs4 is a beneficial or protective factor in
the heart once induced. More recently, and in
support of our observations, Thbs4/ mice
demonstrated greater cardiac decompensation with pressure
overload stimulation (Cingolani et al., 2011).
Thbs4 Induces a Unique ER Stress-Response Signature
in the Heart
We performed a gene expression array analysis to examine why
Thbs4 was cardioprotective; the analysis revealed a remarkable
profile of induced ER chaperones and ER stress-response genes
(data not shown). Western blotting confirmed induction of BiP
(Grp78), Sdf2l1, Creld2, calreticulin, Armet, Hyou1, Mthfd2,
and PDI (Figure 2A). We also observed activation of the PERK
pathway with phosphorylation of eIF2a and induction of down-
stream Atf4, robust induction/activation of Atf6a (cleaved
nuclear form, N terminus), and repression of IRE1a (Figure 2A).
Downstream of IRE1a, we failed to observe activation or splicing
of XBP1 in Thbs4 DTG hearts or in cultured cardiomyocytes with
various stressors (data not shown). Immunohistochemistry from
cardiac tissue sections confirmed induction of BiP, Atf6a, calre-
ticulin, Creld2, and Hyou1 proteins in the hearts of Thbs4 DTG257–1268, June 8, 2012 ª2012 Elsevier Inc. 1259
mice compared with non-TG or tTA controls (Figures 2B and
S3A), as well as induction of Atf6a mRNA in hearts or
AdThbs4-infected neonatal cardiomyocytes in culture (Figure 2C
and data not shown). Interestingly, the induction and processing
of Atf6a were unique among the membrane resident-cleaved
bZIP transcription factor subfamily members, as we observed
no induction or cleavage of Atf6b, Creb3L1, Crebl3L2, Creb3L3,
Creb3L4, or Creb in Thbs4 hearts (Figure S3B). Thbs4 DTG
hearts also showed no changes in the site 1 and site 2 proteases
(S1P and S2P), Srebp1 and Srebp2, or insulin-induced genes 1
and 2 (Insig1 and 2) (Figure S3B).
Ultrastructural analysis by transmission electron microscopy
(EM) revealed a large expansion of the ER and post-ER vesicles
in Thbs4 DTG hearts (Figure 2D). Consistent with this observa-
tion, Thbs4 overexpression by transfection in NIH 3T3 cells
significantly increased secretory capacity, similar to increases
observed with a constitutively nuclear mutant of Atf6a, whereas
Atf4 overexpression suppressed secretion (Figure 2E). Indeed,
adenoviral-mediated overexpression of Thbs4 or Thbs1 in
neonatal cardiomyocyte cultures increased Armet and atrial
natriuretic factor (ANF) levels in the media (Figure 2F). Thus,
Thbs4 induces Atf6a expression and processing to the activated
form, it leads to mild PERK pathway activation, and it results in
expansion of the ER compartment with greater vesicle content
and secretory activity in the heart.
Thbs Proteins Are Likely Universal Inducers of
Protective ER Stress Signaling
To determine whether the ER effects observed with Thbs4 are
a general feature of the Thbs family, we also generated
cardiac-specific (inducible) Thbs1 transgenic mice (Figures
S4A and S4B). Remarkably, Thbs1 DTG mice showed a pattern
of ER stress-response protein induction similar, albeit weaker to
that observed in Thbs4 hearts (Figure S4C). Thbs1 overexpres-
sion also resulted in downregulation of its receptor CD47, but
not CD36 (Figure S4C). To extend this paradigm outside the
heart, we also generated skeletal muscle-specific transgenic
mice that overexpressed either Thbs4 or Thbs1 under control
of the human skeletal a-actin promoter (Figures S4D and S4E).
Remarkably, two separate lines each of Thbs1 and Thbs4 trans-
genic mice showed induction of the same ER stress-response
factors in skeletal muscle as observed in the heart (Figures
S4D and S4E). These results suggest that induction of either
the Thbs1/2 or Thbs3/4/5 subfamily members canmediate upre-
gulation of a unique profile of protective ER stress-response
factors.
Thbs4 Overexpression Protects from Protein
Aggregation-Dependent Cardiomyopathy
The heart is an ideal organ system for investigation of the ER
stress response and the UPR given its susceptibility to protein
aggregation-dependent cardiomyopathy (Wang and Robbins,
2006). For example, point mutations in the intermediate filament
protein desmin or in aB-crystallin can lead to protein aggregation
and disease in the heart, for which mouse models have been
generated (Wang et al., 2001a, 2001b). Separate transgenic
mice expressing either a mutant aB-crystallin (CryAB) or desmin
(DesMut) protein in the heart showed accumulation of ubiquiti-1260 Cell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc.nated proteins and aggregation and deposition of endogenous
desmin, aB-crystallin, and even amyloid formation in the heart
(Figures 3A and 3C). Despite widespread protein aggregates
and accumulation of ubiquitinated proteins, hearts from CryAB
and DesMut transgenic mice showed mild or no upregulation
of ER stress-response genes compared with Thbs4 hearts,
although CryAB and DesMut hearts did produce a unique signa-
ture of Atf6b protein processing (Figures 3A and 3B). By compar-
ison, Thbs4 hearts showed no change in Atf6b processing but
strong Atf6a induction/activation (the cleaved nuclear form is
shown, N terminus), along with large induction of BiP, Armet,
and Sdf2l1 (Figures 3A and 3B). Atf4 protein was also differen-
tially processed between Thbs4 hearts and DesMut hearts
(different isoforms). Thus, Thbs4 produced a specific profile of
ER stress-response factor induction in the heart that was distinct
from the profile observed in twomodels of proteinmisfolding and
aggregation-based cardiomyopathy.
We next crossed Thbs4 DTG mice with both CryAB and Des-
Mutmice, which strongly suggests that Thbs4 overexpression it-
self does not have an unspecific effect or predispose to protein
aggregation. Indeed, Thbs4 overexpression rescued the appear-
ance of protein aggregates in the hearts of DesMut mice as well
as corrected their functional defect in ventricular performance
from the ensuing cardiomyopathy at 6 months of age (Figures
3C and 3D).
In addition to simply enhancing ER functionality and induction
of protective chaperones, the Thbs-dependent adaptive ER
stress response was also associated with upregulated expres-
sion of key proteins underlying the ER-associated protein degra-
dation (ERAD) pathway in the heart (Figure 3E). For example,
increased activity/expression of p97, Edem1, Hrd1, and related
ERAD factors, which are known to augment degradation and
turnover of cytosolic proteins or aggregates, was observed, sug-
gesting another mechanism of protection in CryAB and DesMut
mice (Beskow et al., 2009; Kaneko et al., 2010). Thbs4 hearts
also showed enhanced expression of other protective pathways,
such as autophagy (LC3), and protection from cell death through
upregulation of defender against apoptotic death (DAD1), Atf5,
and Akt (Figure 3F).
Finally, we also instituted a separate cell culture-based model
in which protein aggregation is induced by overexpression of
a mutant cystic fibrosis transmembrane regulator (CFTR) protein
(Kerbiriou et al., 2007). Wild-type CFTR protein is normally
produced in the ER after which it is processed and trafficked
to the membrane, whereas the mutant form of the protein forms
ER aggregates and an ER stress response. Thbs4 co-overex-
pression reduced the appearance of intracellular aggregates
due to CFTR508mut expression in primary mouse embryonic
fibroblasts (MEFs) (Figure S5).
Thbs4 Protects fromwithin the Cell by Shuttling through
the ER
To further investigate Thbs4 signaling/function inside versus
outside the cell, we first examined Thbs4 DTG adult hearts in
which expression was extinguished by feeding the mice Dox
(Figure 4A). The rationale here is that cessation of Thbs4 expres-
sion would first extinguish intracellular regulatory effects,
whereas any potential accumulation outside the cell should
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Figure 3. Thbs4 Induces a Unique ER Stress-Response Signature that Antagonizes Protein Aggregation and Disease in the Heart
(A and B) Western blots showing ER protein expression in (A) aB-crystallin (CryAB) mutant or (B) desmin (DesMut) mutant hearts in comparison to nontransgenic
(NTG) and Thbs4 DTG hearts. The hash marks or arrowheads show the different isoforms that were detected.
(C) Immunohistochemistry of frozen heart sections from 6-month-old mice of the indicated genotypes. Protein aggregation (green color) is dramatically reduced
when Thbs4 is overexpressed. Red staining is for actin and shows the outline of cardiomyocytes (scale bars = 100 mm).
(D) FS% as determined by echocardiography suggests that cardiac function is improved in both aggregation-prone cardiomyopathic transgenic mouse models
when Thbs4 is overexpressed (n = 6 or more mice in each group, *p < 0.05 versus tTA; #p < 0.05 versus DesMut; yp < 0.05 versus CryAB).
(E)Western blotting for proteins involved in ERAD from the hearts of Thbs4 DTGmice versus tTA control hearts. The arrowheads show the positions of the relevant
proteins, whereas the bracket shows two relevant bands.
(F) Western blotting for proteins involved in autophagy (LC3, both I and II isoforms) or cellular protection.
Also see Figure S5.provide a more stable signal if it integrated into the ECM.
However, within 1 week of Thbs4 protein shut-down, induction
of BiP, Atf4, and Atf6a was lost, although a residual increase in
calreticulin was observed and likely reflects initial ER expansion
due to prior Thbs4 overexpression (Figure 4A). These results
suggest that Thbs4 has its protective effect by events initiated
from inside the cell and not through a stable reservoir in the
ECM or some other aggregated source.
To further investigate the site of Thbs4 action, we used
a recombinant adenovirus to overexpress Thbs4 in cultured
neonatal cardiomyocytes, which again demonstrated ER/Golgi
staining, although secretion in the media was observed (Figures
4B and 4D). Induction of Atf4 and Atf6a (nuclear-processed form)
was only observed when cardiomyocytes were infected
with AdThbs4, but not with recombinant Thbs4 supplied to
the media or with conditioned media from prior AdThbs4-
infected cardiomyocytes (Figure 4C and data not shown). Tuni-
camycin, a known ER stress-inducing agent, is shown as
a control (Figure 4C).
We used a retention/recycling signal in the primary sequence
(KDEL) to engineer a recombinant version of Thbs4 that is re-tained in the ER. Remarkably, the ER-resident version of Thbs4
was unable to induce Atf6a and the known profile of ER stress-
factor responsiveness observed with WT Thbs4 (Figure 4E).
This is consistent with Thbs4 functioning more directly on
Atf6a as it translocates from the ER to the Golgi, then the nucleus
once cleaved. The inability of the Thbs4-KDEL mutant to induce
an ER stress response further suggests that the effects we
observe with standard Thbs4 overexpression are not due to
unspecific conditioning within the ER or overloading/aggrega-
tion of Thbs4 protein in the ER.
RT-PCR analysis showed that the ER stress responses
generated by DTT or tunicamycin each induced endogenous
Thbs4 expression in neonatal cardiomyocytes (Figure 4F).
Importantly, overexpression of Thbs4 in neonatal cardiomyo-
cytes was protective, similar to data obtained in the DTG
mice, as less ER stress-dependent cell death was observed
following DTT application (Figure 4G). Collectively, these
results suggest that Thbs4 functions from within the cell,
as vesicles shuttle between the ER and Golgi and onward,
to induce an adaptive stress response that protects from
cell death.Cell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc. 1261
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Figure 4. Thbs4 Functions from within the Cell to Promote Adaptive ER Stress-Response Signaling
(A) Western blots of ER stress-response protein expression in heart extracts from 3-month-old tTA and DTG mice fed chow containing doxycycline for the
indicated periods of time to extinguish Thbs4 expression. ‘‘No dox’’ controls are also shown and were generated from extracts of 4-month-old DTG mice. An
N-terminal Atf6a antibody from ProSci was used. The arrowheads show the specific bands that were detected; ns = nonspecific.
(B) Immunocytochemistry for Thbs4 in adenovirus-infected neonatal cardiomyocytes showing that Thbs4 (green) has an ER and Golgi staining pattern. Red
staining is for membranes, and blue stains the nuclei (scale bars = 10 mm).
(C) Western blotting for Atf4 and Atf6a protein expression in neonatal rat cardiomyocytes infected for 24 hr with recombinant adenovirus or treated with re-
combinant Thbs4 (2 mg/ml) or tunicamycin (1 mg/ml).
(D) Western blotting from media for Thbs4 after AdThbs4 infection versus Adbgal control in neonatal cardiomyocytes. Ponceau staining is a control for protein
loading between the samples.
(E) Western blotting for ER stress-response proteins from neonatal cardiomyocytes following infection with a control (Adbgal) adenovirus or an adenovirus
expressing Thbs4 fused with a KDEL ER retention/relocalization signal.
(F) RT-PCR for Thbs4 or Gapdh in neonatal cardiomyocytes treated for 5 hr with ER stress inducers DTT (5 mM) or tunicamycin (10 mg/ml).
(G) AlamarBlue survival assay in DTT-treated (8 hr, 4 mM) neonatal cardiomyocytes infected with AdThbs4 or Adbgal (assay was run in duplicate in three separate
experiments; #p < 0.05 versus vehicle; error bars represent SD).Thbs4 Directly Binds ATF6a to Mediate Its Processing
and Activation
A GST-Thbs4 fusion protein was next generated to permit
protein pull-downs followed by western blotting of suspected
ER regulatory candidates from Thbs4 heart protein extracts.
Thbs4 did not interact with calreticulin, Armet, or BiP, but it
did prominently interact with Atf6a, both the full-length form
and, more preferentially, the C terminus that corresponds to
the ER lumenal domain (Figures 5A and 5B). In vitro transcrip-
tion-translation products of Atf6a corresponding to the lumenal
domain (aa 361–656) and a smaller more C-terminal region
(aa 471–656) each boundGST-Thbs4 but not GST alone (Figures
5B and 5C). Importantly, the lumenal domain of Atf6b did not
bind GST-Thbs4, but GST-Thbs1 that similarly contains type 3
repeats also bound the Atf6a lumenal domain (Figures 5C and
5D). Indeed, overexpression of Thbs1 in neonatal rat cardiomyo-
cytes with a recombinant adenovirus also induced a profile of
adaptive ER stress-response factor expression similar to that
observed with Thbs4 (data not shown), similar to Thbs1 and
Thbs4 DTG hearts.
We used the Gal4 transcription factor fused to three different
regions of the Atf6a lumenal region to further refine the binding
domain within human Atf6a. These Atf6a-Gal4 fusion constructs1262 Cell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc.were transfected into HEK293 cells with a Gal4-dependent
luciferase reporter, with or without a Thbs4 expression plasmid.
Thbs4 coexpression enhanced Gal4 reporter activity of Atf6a
fusions containing amino acids 370–670 and 370–589, but not
370–468, suggesting a minimal region of 468–589 as the inter-
acting domain in Atf6a (Figure 5E). This region is not conserved
within Atf6b. We also analyzed the domains in Thbs4 that might
interact with the lumenal domain of Atf6a using GST fusion
fragments, which identified the calcium-binding type 3 repeat
region (Figure 5F). Immunoprecipitation of full-length Atf6a
from Thbs4 hearts, but not control tTA hearts, showed interac-
tion with Thbs4 in vivo (Figure 5G). In conclusion, these results
suggest a mechanism whereby Thbs conditions an adaptive
ER stress response, in part, by interacting with Atf6a.
Thbs4/ Mice Show Defective Induction of the ER
Stress Response in the Heart
Overexpression of Thbs4 in neonatal rat fibroblasts also caused
translocation and nuclear accumulation of endogenous Atf6a
protein compared with very little nuclear localization of Atf6a in
Adbgal-infected controls (Figure 6A). This dramatic increase in
nuclear content of Atf6a due to Thbs4 overexpression was
prevented with AEBSF (Okada et al., 2003), a S1P-specific
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Figure 5. Thbs Proteins Directly Interact with Atf6a
(A) Western blot following GST-Thbs4 pull-down of the indicated proteins from cardiac protein extracts from Thbs4 DTG hearts. A C-terminal Atf6a antibody from
ProSci was used.
(B) Mouse Atf6a schematic diagram showing relative size of the lumenal domains used for GST pull-down experiments (red bars).
(C) Western blot for tagged truncations of two different Atf6a lumenal domains following GST-Thbs4 pull-down. The ER lumenal domain of Atf6b did not interact
with GST-Thbs4. There is a nonspecific band in the GST (Atf6a 471-656) only lane due to extreme loading of purified GST.
(D) Western blot for a tagged Atf6a lumenal domain (amino acids 361–656) following GST-Thbs1 pull-down.
(E) Gal4-dependent luciferase reporter activity with the lumenal fragments of Atf6a (amino acid numbers shown) as fusions to full-length Gal4 transiently
transfected into HEK293 cells with or without Thbs4. The basal activity of each construct was set to 100, fromwhich Thbs coexpression was compared. *p < 0.05
versus no Thbs4 control. Results are averaged from three separate experiments.
(F) Schematic diagram of human Thbs4 with the relative sizes of the GST fragments indicated (red bars). A western blot for the Atf6a lumenal domain with a Flag
antibody following GST pull-down with the different Thbs4 domains, depicted below the schematic.
(G) Western blot for Thbs4 and Atf6a (FL, full-length is shown detected with ProSci C-terminal antibody) after Atf6a immunoprecipitation (with N-terminal Abcam
antibody) from cardiac extracts of control tTA or Thbs4 DTG hearts.protease inhibitor, showing that Thbs4-dependent activation of
Atf6a occurs before nuclear translocation, likely in the Golgi
(Figure 6A).
To gain further insight into the necessity of Thbs4 as amediator
of the ER stress response in the heart, we further analyzed
Thbs4/ mice. Importantly, although four Thbs genes are
expressed in the heart (1/2/3/4), Thbs4 is the most highly
expressed compared with other tissues, and it appears to be
of greatest inducibility in collective gene arrays from diseased
hearts (Lawler et al., 1993, 1995; data not shown). As expected,
hearts from surviving Thbs4/ mice after 48 hr of TAC stimula-
tion showed defective Atf6a induction (nuclear form, N terminus),
with no or less induction of BiP, PDI, calreticulin, Armet, and Atf4
(Figure 6B). Indeed, the observed immediate translocation of
Atf6a protein to the nuclei of hearts from WT mice after 24 hr
of TAC was lost in Thbs4/ mice (Figure 6C). These same
ER stress factors were also induced 3 days after MI injury inWT hearts, but again this induction was lost or blunted in
Thbs4/mice (Figure 6D). We also enzymatically disassociated
and cultured adult cardiomyocytes (4–8 hr) from WT and
Thbs4/ hearts, a process that spontaneously induced an
ER stress-response signature in the WT cells but much less so
in the nulls (Figure 6E). Consistent with these observations,
isolated myocytes from Thbs4/ hearts in culture were more
susceptible to tunicamycin-induced killing than were isolated
adult cardiacmyocytes fromWT control mice (Figure 6F). Collec-
tively, these results suggest that induction of Thbs4 protein in
the mouse heart is required to fully induce an adaptive
ER stress response.
Mechanism of Thbs4-Mediated Adaptive ER Stress
Signaling
To probe more deeply into the mechanism whereby Thbs might
activate Atf6a, we generated a recombinant adenovirus thatCell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc. 1263
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Figure 6. Thbs4 Is Necessary for Atf6a Activation in the Heart
(A) Immunocytochemistry for Atf6a in neonatal rat fibroblasts with Adbgal (control) or AdThbs4 infection, with or without the S1P inhibitor AEBSF. The arrows
show prominent nuclear localization of Atf6a, whereas the arrowheads show Atf6a retention in the Golgi and ER. (scale bars = 10 mm).
(B) Western blots showing ER stress-response protein expression in hearts of WT and Thbs4/mice at baseline (sham) or after 48 hr of TAC stress stimulation.
Arrowheads show the indicated protein.
(C) Immunohistochemistry for Atf6a following 24 hr TAC or a sham surgical procedure. Nuclear-localized Atf6a (arrowheads) was much more prominent in WT
hearts after TAC relative to Thbs4/ hearts with TAC (scale bars = 10 mm).
(D) Western blots showing ER stress-response protein expression in hearts of WT and Thbs4/ mice at baseline (sham) or 3 days after MI injury.
(E) Western blot for ER stress-response protein expression from isolated adult myocytes in temporary culture from WT or Thbs4/ hearts.
(F) AlamarBlue survival assay in tunicamycin-treated adult cardiomyocytes isolated from WT or Thbs4/ hearts (assay was run in duplicate; *p < 0.05 versus
vehicle; error bars represent SD).
Also see Figure S6.expressed amino acids 448–570 of mouse Atf6a and that con-
tained the minimal Thbs4-binding domain to act as a dominant
negative (DN) (Figure 7A). A signal and KDEL sequence were
included to ensure proper residence within the ER compartment.
Infection with AdAtf6a DN blocked the ability of coinfected
AdThbs4 to fully induce nuclear Atf6a, as well as protein induc-
tion of Atf4, Armet, and calreticulin in cultured neonatal cardio-
myocytes (Figure 7B). We also generated a dominant-negative,
ER-retained Thbs4 mutant encoding only the type 3 repeat
region that binds Atf6a (Figure 7C). Similar to the Atf6a(DN)
construct, AdThbs4(DN) attenuated the ability of AdThbs4 coin-
fection to fully upregulate expression of Atf6a, Atf4, Armet, calre-
ticulin, and PDI in cultured neonatal cardiomyocytes (Figure 7D).
Consistent with these results, both AdAtf6a(DN) and
AdThbs4(DN) blocked Thbs4-induced nuclear translocation
and nuclear accumulation of endogenous nuclear/cleaved
Atf6a (N terminus) in primary fibroblast cultures (Figure 7E).
Atf6a(DN) and Thbs4(DN) also blocked or significantly reduced
that activity of Atf6a-Gal4 for a Gal4-dependent luciferase
reporter as stimulated by Thbs4 cotransfection in HEK293 cells
(Figure 7F). Finally, overexpression of Thbs4(DN) blocked tunica-
mycin stress-induced activation of endogenous Atf6a (nuclear
form) in cultured neonatal cardiomyocytes (Figure 7G). Taken
together, these results suggest that Thbs4 directly regulates1264 Cell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc.Atf6a as a specific mechanism in mediating the adaptive
ER stress response.
To extend the results obtained with dominant-negative Thbs4
and Atf6a, we also utilized Atf6a null MEFs. If Atf6a is truly the
primary mechanism for mediating the protective ER stress-
response profile downstream of Thbs4, its absence should
reduce Thbs4-dependent protection. Indeed, WT MEFs treated
with DTT or tunicamycin showed enhanced cell death, which
was significantly reduced by AdThbs4 infection (Figure 7H).
However, Atf6a null MEFs, which showed even greater killing
with DTT and tunicamycin compared with WT MEFs, were not
protected with AdThbs4 infection, suggesting that Atf6a is
a primary mediator underlying Thbs4-dependent protection
from ER stress-associated cell death (Figure 7H).
DISCUSSION
Once induced in select tissues, Thbs protein expression can be
observed directly within cells or between cells in the extracellular
space (Chen et al., 2000; So¨dersten et al., 2007; Veliceasa et al.,
2007; Greco et al., 2010). We observed prominent Thbs4 protein
localization within the ER/SR compartment of adult cardiomyo-
cytes of the heart, with some mild accumulation in the extracel-
lular space or ECM. Indeed, although Thbs’ are generally
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(A) Schematic diagram of the region of mouse Atf6a that was used to make the dominant-negative or decoy adenovirus (red bar).
(B) Western blotting for the indicated proteins from neonatal cardiomyocytes infected with the indicated recombinant adenoviruses. The red-boxed areas show
induction of ER stress-response proteins by Thbs4 overexpression, which is attenuated with the Atf6a DN-expressing adenovirus.
(C) Schematic diagram of the region of Thbs4 that was used to make the dominant-negative or decoy adenovirus (red bar).
(D) Western blotting for the indicated proteins from neonatal cardiomyocytes infected with the indicated recombinant adenoviruses. The red-boxed areas show
induction of ER stress-response proteins by Thbs4 overexpression, which is attenuated with the Thbs4 DN-expressing adenovirus.
(E) Immunocytochemistry for endogenous Atf6a in cultured neonatal rat fibroblasts 24 hr after infection with the indicated adenoviruses. The arrows show
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Also see Figure S6.secreted, examples of their intracellular retention in the ER or
vesicles have been reported (Chen et al., 2000; So¨dersten
et al., 2007; Veliceasa et al., 2007; Hauser et al., 1995; Greco
et al., 2010). Thbs’ are assembled into trimers (Thbs1 and 2) or
pentamers (Thbs3, 4, and 5) in the ER, and Thbs1 was shown
to be part of a complex with PDI, BiP, p72, and Grp94 and to
reside in the ER compartment for up to 30 min before presum-
ably shuttling to the Golgi for glycosylation (Prabakaran et al.,
1996; Kuznetsov et al., 1997; Hecht et al., 2001). More provoca-
tively, Thbs1 is retained in the ER in response to low calcium
levels in renal cell carcinoma tissue and cultured cells, whereas
restoration of ER calcium permits Thbs1 secretion (Veliceasa
et al., 2007). Thus, Thbs’ could easily have a primary function
in the ER or other associated intracellular vesicular compart-
ments, either as they are being produced in complexes withknown ER stress chaperones or ECMproteins, or if theymaintain
residence in the ER long-term, as regulators of the ER stress
response in conjunction with calcium sensing.
Here we identified a role for Thbs in the ER stress response to
presumably enhance the ability of a cell to secrete proteins,
properly reconstruct the ECM after injury, and deal with unfolded
proteins during disease. We determined that the type 3 repeat
domain in Thbs4 directly binds to Atf6a to facilitate its activation
(Figure S6). All five Thbs contain this calcium-binding type 3
repeat domain, although its function remains essentially
unknown (Kazerounian et al., 2008). Here we propose a working
hypothesis that accounts for induction of all five Thbs genes
during injury or tissue remodeling, incorporates the fact that
these proteins are resident in the ER-vesicular network, and
builds from our new observations related to Atf6a activation byCell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc. 1265
Thbs4 (Figure S6). We propose that the type 3 repeat domain in
Thbs’ activates Atf6a to upregulate the protective ER stress
response. Increased Atf6a activity is known to expand the
ER compartment and upregulate other ER stress-response
effectors and chaperones (Adachi et al., 2008; Bommiasamy
et al., 2009). In addition, a previously published mRNA expres-
sion analysis from mice containing a tamoxifen-inducible acti-
vated Atf6a transgene for heart-specific expression showed
a very similar profile of enhanced ER stress-response genes as
our microarrays from Thbs4 DTG hearts, suggesting that Atf6a
is the primary mediator of Thbs effects in the heart (Belmont
et al., 2008; Martindale et al., 2006). It is also interesting to spec-
ulate that Thbs4might bemore evolutionarily divergent as a dedi-
cated mediator of this adaptive ER stress/conditioning effect
with injury compared with Thbs1 and 2. Indeed, loss of Thbs4/
in the mouse compromised the ER stress-response activation
profile that is normally observed with acute injury to the heart,
despite known induction and presence of Thbs1 and Thbs2
with cardiac injury (Schellings et al., 2009).
A critical observation that supports the importance and func-
tion of the type 3 repeat domain comes from known COMP
(encodes Thbs5 protein) mutations that cause genetic diseases
resulting in skeletal dysplasia (Briggs et al., 1995; Hecht et al.,
1995). Such mutations in COMP occur within the type 3 repeat
domain, which appears to affect COMP’s function and ability
to traverse the ER compartment (Hecht et al., 2001; Hashimoto
et al., 2003). Indeed mutations in this type 3 repeat region of
COMP cause its retention in the ER, coretention of type IX
collagen and aggrecan, sequestration of several ER stress
chaperones, and enlargement of the rER compartment (Hecht
et al., 1998; De´lot et al., 1999; Vranka et al., 2001; Chen et al.,
2007). The inability of the mutant Thbs5 protein to leave the ER
and be secreted causes a maladaptive ER stress response
leading to cellular apoptosis (Hashimoto et al., 2003). These
results suggest that the type 3 repeat domain is critical for proper
ER conditioning and processing of Thbs proteins once gener-
ated, which also directly affects overall ER function and the
ability to properly produce and secrete other ECM proteins.
These results also suggest that Thbs proteins may have a chap-
erone-like function for processing large ECM-fated proteins for
their construction outside the cell after injury. Interestingly, this
type 3 repeat domain in Thbs’ binds calcium where it could
also serve to sense the health of the ER environment. Indeed,
reductions in ER calcium are known to cause Thbs1 ER retention
and lack of secretion (Veliceasa et al., 2007).
Although Thbs4 produced a protective ER stress response
through Atf6a activation, we cannot exclude other protective
functions of Thbs4 in the ER or associated vesicles that might
be separate from Atf6a. Indeed, proteins that underlie ERAD
were specifically upregulated in Thbs4 DTG hearts. Another
possibility is that Thbs4 itself might function to enhance vesicular
trafficking through the secretory pathway to help move more
traditional ECM-targeted proteins outside the cell. Indeed,
whereas the ER was expanded in Thbs4 DTG hearts, we
also observed a large increase in total vesicles throughout the
cytosol and near the plasma membranes of cardiomyocytes,
suggesting enhanced trafficking. We also observed by EM
increased markers of autophagy (LC3) and signs of greater auto-1266 Cell 149, 1257–1268, June 8, 2012 ª2012 Elsevier Inc.phagic vesicles, especially in Thbs1 DTG hearts (Figure 3F and
data not shown). However, it is also possible that simply
mobilizing Atf6a mediates all or much of the protective and
adaptive ER functions observed in Thbs4 DTG hearts, especially
given the results with the decoy pieces of Thbs4 (type 3
repeat domain) and the dominant-negative lumenal portion of
Atf6a. Although PERK and Atf4 were mildly activated in
Thbs4 DTG hearts or by AdThbs4 infection in neonatal cardio-
myocytes, this effect could also be due to a primary change
in Atf6a, which secondarily changes BiP levels or other
ER stress-regulatory factors to possibly favor PERK activation.
IRE1a was noticeably downregulated by Thbs4 overexpression,
which again could be due to adaptive secondary changes
associated with Atf6a.
Our results show a unique paradigm whereby these Thbs
proteins contain within their primary sequence all the necessary
domains for ER adaptation and greater construction or turnover
of the ECM with injury or disease. Thbs proteins contain a highly
conserved domain that functions to condition the ER when
expressed through a direct effect on Atf6a that results in expan-
sion of the ER for greater capacity, along with more protective
chaperones that aid in generation of complex ECM proteins
(Figure S6). Thbs proteins also bind various ECM proteins where
they likely facilitate their processing and eventual extrusion into
the ECM, after which Thbs proteins are likely degraded. Such
built-in heterofunctionality allows inherent coordination of extra-
cellular milieu content or dynamic extracellular replacement
events with increased functioning of the ER and vesicular traf-
ficking (Figure S6). Such conditions most likely arise after injury
in adult tissues or during active developmental remodeling, or
when ER calcium levels are altered during chronic disease.
EXPERIMENTAL PROCEDURES
Animals
Mice were produced by transgenesis to overexpress Thbs4 (and Thbs1) in the
heart using a regulated binary system based on the tetracycline transactivator
protein and the tet-operator in a modified a-myosin heavy chain promoter
(cardiac-specific). All transgenicmicewere in the FVB/N background, whereas
Thbs4/ mice were obtained from Jackson laboratories and were in the
C57BL/6-SV129 background.
Western Blotting, Immunohistochemistry, and
Immunocytochemistry
Hearts from mice were processed according to routine protocols to permit
immunohistochemistry and processing for protein extracts for western blot-
ting. Cultured neonatal rat cardiomyocytes, primary fibroblasts, and NIH 3T3
and HEK293 cells were also used throughout the study for mechanistic exper-
iments with or without adenoviral infection to manipulate expression of Thbs1,
Thbs4, Atf6a, or truncation mutants of Atf6a and Thbs4 that served as domi-
nant negatives. Cells were fixed with cold methanol followed by 1 min perme-
abilization in cold acetone, washed, processed, and incubated with primary
antibody at typical dilutions of 1:100. Dilutions for immunohistochemistry
were 1:200 to 1:1000.
Cell Culture, Adenovirus Infection, and RT-PCR
Primary neonatal rat cardiomyocytes were prepared from 1- to 2-day-old
Sprague-Dawley rat pups and plated at 1.5 3 106 cells per 10 cm dish in
2%bovine growth serum. Cardiomyocytes or MEFs were infected with adeno-
virus for 2–6 hr and then fresh media applied. Cells were harvested 24 to 72 hr
post-infection. For RT-PCR, RNA was isolated from either tissue or cells using
the QIAGEN fibrous tissue kit coupled with the QIAGEN QIAShredder
according to manufacturer instructions. Invitrogen SuperScript III One-Step
RT-PCR system was then used.
Transfections, Luciferase Assays, GST Pull-Down, and EM
FuGENE6 was utilized for transfection of NIH 3T3 and HEK293 cells according
to manufacturer instructions. The 9xGAL4-luciferase reporter was cotrans-
fected with pSV-b-galactosidase control vector to measure Gal4-Atf6a fusion
domain function with Thbs4 overexpression. Forty-eight-hours post-transfec-
tion cells were harvested in lysis buffer, and standard extracts generated to
measure luciferase activity. GST pull-down assays were used to investigate
Thbs1 and Thbs4 interaction with Atf6a. For these experiments, a GST-
Thbs4 fusion plasmid was transformed into BL21-competent E. coli, and the
fusion protein was isolated for pull-downs with transcription-translation
(TNT) lysate-generated experimental proteins of interest. EM with standard
processing and imaging was used to visualize ultrastructural features in the
hearts of Thbs4 DTG mice. A full detailed description of the experimental
procedures can be found in the Extended Experimental Procedures online.
SUPPLEMENTAL INFORMATION
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